Skip to main content
. 2017 Sep 19;7(9):279. doi: 10.3390/nano7090279

Figure 13.

Figure 13

ROS and GSH levels in normal skin (a,c) and lung (b,d) cells at 24 and 48 h exposure to 100 and 200 μg/mL of the two TiO2/RGO nanocomposites samples (A and B) and commercially available TiO2 NPs (P25). Data are calculated as means ± standard deviation (SD) (n = 3) and showed relative to control (untreated cells). * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. control.